What is BioPro?
Established in 1987, BioPro Implants has carved out a specialized niche in the design and production of high-quality orthopedic devices. The company provides a comprehensive portfolio of solutions, ranging from foot and ankle reconstruction to advanced total joint systems and biologics. By focusing on both time-tested methodologies and modern technological advancements, BioPro serves a critical role in the healthcare ecosystem, providing surgeons with the tools necessary to treat complex conditions such as arthritis and structural deformities. Their market position is defined by a legacy of reliability and a persistent focus on patient outcomes, making them a cornerstone provider for orthopedic clinics worldwide.
How much funding has BioPro raised?
BioPro has raised a total of $747K across 2 funding rounds:
Debt
$350K
Debt
$397K
Debt (2020): $350K with participation from PPP
Debt (2021): $397K led by PPP
Key Investors in BioPro
PPP
Public-Private Partnership
What's next for BioPro?
The infusion of capital from this latest financing round is expected to accelerate BioPro's research and development initiatives, particularly in the realm of next-generation biologics and minimally invasive surgical implants. As the company transitions into this new phase of enterprise-level growth, management is likely to prioritize the optimization of supply chain logistics and the expansion of their distribution network. By leveraging this strategic backing, BioPro is well-positioned to capture additional market share, enhance its competitive advantage in the medical device industry, and continue its trajectory of innovation in orthopedic care.
See full BioPro company page
